Clinical Trials Sponsored by MidAtlantic Retina

Total 619 results

MidAtlantic Retina

Completed

Thrombospondin-1 and Pigmented Epithelium Derived Factor Levels in Patients With Diabetes Mellitus. (PEDF)

Diabetes Mellitus | Diabetes

United States
MidAtlantic Retina

Unknown

Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections

Age-related Macular Degeneration | Retina Vein Occlusion | Diabetic Vascular Diseases | Proliferative Retinopathy

United States
MidAtlantic Retina
Alcon Research

Completed

Comparision of Retinal Surgery by Three-dimensional Heads-up Display to the Standard Operating Microscope

Comparison of 3D Visualization and Microscope for VR Surgery

United States
MidAtlantic Retina
Regeneron Pharmaceuticals

Completed

Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration (ATLAS)

Age-Related Macular Degeneration | Macular Degeneration

United States
Retina Research Institute, LLC
Valley Retina Institute

Unknown

Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results

Age Related Macular Degeneration

United States
MidLantic Urology
Blue Earth Diagnostics

Not yet recruiting

Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

Prostate Cancer

United States
Retina Health Center
Genentech, Inc.; California Retina Consultants

Unknown

Assessment of Comfort Level Following an Intravitreal Injection by 30 or 32 Gauge Needles

Pain

United States
Mid Atlantic Retina

Completed

Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy

Retinal Detachment | Macular Hole

United States
Retina Implant AG

Terminated

Impact on Daily Life of Patients Using the Subretinal Implant RETINA IMPLANT Alpha AMS

Retinal Degeneration | Inherited Retinal Dystrophy Primarily Involving Sensory Retina

France
Retina Implant AG

Withdrawn

PMCF Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS

Retinitis Pigmentosa

Germany
Retina Implant AG

Completed

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Retinal Degeneration | Retinitis Pigmentosa

Germany, Hungary, United Kingdom
Valley Retina Institute

Unknown

Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN (ELYSIAN)

Proliferative Diabetic Retinopathy
Mid Atlantic Retina

Unknown

A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye

Age-related Macular Degeneration | Central Retinal Vein Occlusion | Choroidal Neovascularization | Branch Retinal Vein Occlusion

United States
Retina Research Foundation

Completed

Scotoma Reduction in AMD Patients Treated With Ranibizumab (SALVAGE)

Macular Degeneration

United States
Barnes Retina Institute

Unknown

Intraocular Pressure Accuracy and Variability of the Barraquer Tonometer

Elevated Intraocular Pressure

United States
California Retina Consultants

Completed

Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study) (PAVE)

Diabetic Retinopathy | Age-related Macular Degeneration | Diabetic Macular Edema

United States
California Retina Consultants

Completed

Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab (ERASER)

Diabetic Macular Edema

United States
Barnes Retina Institute

Completed

Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and Controls

Nuclear Sclerotic Cataract

United States
Valley Retina Institute

Unknown

Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion (ORION)

Central Retinal Vein Occlusion | Macular Edema

United States
Elman Retina Group

Completed

Squalamine for the Treatment in Proliferative Diabetic Retinopathy

Retinal Neovascularization

United States
Valley Retina Institute

Completed

Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study (PRESERVE)

Diabetic Macular Edema

United States
Mid Atlantic Retina

Completed

Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments

Diabetic Retinopathy | Retinal Detachment | Vitrectomy | Proliferative Vitreoretinopathy

United States
Illinois Retina Associates

Completed

Patient Assessment of Topical Anesthetic Effectiveness for Intravitreal Injections

Pain

United States
Retina Research Foundation

Unknown

Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV) (ITVR)

Macular Degeneration | Diabetic Retinopathy

United States
Retina Macula Institute

Completed

Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration

Neovascular Age Related Macular Degeneration

United States
Texas Retina Associates

Completed

Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion

Non-Ischemic Central Retinal Vein Occlusion

United States
Retina Implant AG

Completed

Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Retinal Degeneration | Retinitis Pigmentosa

Hong Kong
California Retina Consultants

Unknown

Analysis of Aqueous and Vitreous Humor (ARK)

Macular Degeneration | Proliferative Diabetic Retinopathy | Neovascular Glaucoma | Macular Hole

United States
California Retina Consultants

Completed

Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF

Age-related Macular Degeneration | Diabetic Macular Edema | Retinal Vein Occlusion
Retina Implant AG

Completed

Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors

Retinitis Pigmentosa

Germany
Barnes Retina Institute

Unknown

Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma

Uveal Melanoma

United States
Angle plc
MidLantic Urology, LLC

Terminated

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System (CHARTER)

Prostate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate Carcinoma

United States
Retina Research Institute, LLC
Retina-Vitreous Associates Medical Group; West Coast Retina Medical Group,...

Terminated

Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF

Macular Edema | Retinal Vein Occlusion (RVO)

United States
Greater Houston Retina Research

Not yet recruiting

Aqueous Biomarker Levels in Diabetic Retinopathy and Diabetic Macular Edema (DRAGONS)

Diabetic Retinopathy | Diabetic Macular Edema | Other Retinal Disorders
RETINA-AI Health, Inc.

Completed

Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

Diabetes | Diabetic Retinopathy | Diabetic Macular Edema | Diabetic Eye Problems

United States
Retina Macula Institute
Allergan

Completed

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Diabetic Macular Edema | Proliferative Diabetic Retinopathy | Non-proliferative Diabetic Retinopathy

United States
Retina Research Institute, LLC

Completed

Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome

Choroidal Neovascularization | Presumed Ocular Histoplasmosis

United States
Tennessee Retina
Regeneron Pharmaceuticals

Unknown

On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD) (ROLL)

Age Related Macular Degeneration | Pigment Epithelial Detachment

United States
Texas Retina Associates
Novartis

Completed

Ranibizumab and Reduced Fluence PDT for AMD (RAP)

Macular Degeneration

United States
New England Retina Associates

Withdrawn

Ranibizumab as a Rescue Therapy for Diabetic Macular Edema

Diabetic Macular Edema

United States
Greater Houston Retina Research

Completed

Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion

Ischemic Central Retinal Vein Occlusion

United States
Seoul Retina Investigator Group

Unknown

Early Vitrectomy for Impending Macular Hole

Retinal Perforation

Korea, Republic of
RETINA-AI Health, Inc.

Completed

Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device

Diabetic Retinopathy | Diabetic Macular Edema | Diabetic Eye Problems

United States
Bursa Retina Eye Hospital

Completed

Refractive Changes Following Vitrectomy

Refractive Errors | Vitreous Hemorrhage | Retinal Detachment | Epiretinal Membrane

Turkey
Retina Macula Institute
Allergan

Completed

Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.

Macular Edema | Retinal Vein Occlusion

United States
New England Retina Associates

Completed

Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma

Choroidal Melanoma

United States
Southeast Retina Center, Georgia

Unknown

Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH (LASERLESS)

Proliferative Diabetic Retinopathy

United States
Barnes Retina Institute
Allergan

Completed

Anatomic Outcomes Following Ozurdex Injections

Retinal Vein Occlusions

United States
Retina Specialists, PC
Allergan

Completed

Ozurdex for Macular Edema Post Membrane Peeling

Macular Edema | Epiretinal Membrane | Retinal Edema | Cellophane Maculopathy

United States
Greater Houston Retina Research

Withdrawn

A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy (No-Crunch01)

Proliferative Diabetic Retinopathy

United States

Clinical Trials Sponsored by MidAtlantic Retina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations